AnaptysBio (ANAB) Stock Chart & Stock Price History $23.88 +1.23 (+5.43%) Closing price 04:00 PM EasternExtended Trading$23.90 +0.02 (+0.06%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio Stock Price Performance The AnaptysBio (ANAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 0.25%, with a year-to-date return of 80.36%. In the past month, the stock has increased 9.24%, reflecting recent market activity. As of the latest close, AnaptysBio traded at $22.65 with a market cap of $665.46 million and volume of 336,072 shares. Five years ago, the stock traded at $22.54, representing a 5.94% increase over that period. At the time, it had a market cap of $609.37 million and a volume of 182,184 shares. Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.28%1 Month Performance+9.24%3 Month Performance+25.88%Year-To-Date Performance+80.36%1 Year Performance-0.25%5 Year Performance+5.94% ANAB Stock Chart for Wednesday, July, 2, 2025 ANAB Chart by TradingView AnaptysBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$22.65$23.88+5.43%$24.69$22.43669,369 shs$701.59 million07/01/2025$22.20$22.65+2.03%$23.09$21.87336,072 shs$665.46 million06/30/2025$22.47$22.20-1.20%$22.83$21.96525,155 shs$652.24 million06/27/2025$23.38$22.47-3.89%$23.53$22.19545,336 shs$660.17 million06/26/2025$23.24$23.38+0.60%$24.86$22.89298,242 shs$686.90 million06/25/2025$23.32$23.24-0.34%$23.59$22.49366,689 shs$682.79 million06/24/2025$22.82$23.32+2.19%$23.80$22.90403,991 shs$685.14 million06/23/2025$23.17$22.82-1.51%$23.94$22.35439,599 shs$670.45 million06/20/2025$23.39$23.17-0.94%$23.45$22.51454,361 shs$680.74 million06/19/2025$23.39$23.39$24.17$23.03419,414 shs$687.20 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$23.82$23.39-1.81%$24.17$23.03419,414 shs$687.20 million06/17/2025$23.90$23.82-0.33%$24.15$23.49525,264 shs$699.83 million06/16/2025$23.32$23.90+2.49%$24.03$22.66554,548 shs$702.18 million06/13/2025$23.41$23.32-0.38%$23.71$22.46378,901 shs$685.14 million06/12/2025$23.60$23.41-0.81%$24.22$23.13498,268 shs$687.79 million06/11/2025$23.97$23.60-1.54%$24.37$23.36859,300 shs$693.37 million06/10/2025$23.19$23.97+3.36%$24.29$23.02790,329 shs$704.24 million06/09/2025$23.70$23.19-2.15%$24.41$22.28505,009 shs$681.32 million06/06/2025$21.14$23.70+12.11%$24.01$20.93840,957 shs$696.31 million06/05/2025$21.27$21.14-0.61%$21.32$19.041.18 million shs$621.09 million06/04/2025$23.52$21.27-9.57%$24.68$20.251.97 million shs$624.91 million06/03/2025$21.86$23.52+7.59%$24.16$21.711.01 million shs$691.02 million06/02/2025$22.45$21.86-2.63%$22.82$21.79666,792 shs$642.25 million Related Companies Immunovant Stock Chart HUTCHMED Stock Chart Organon & Co. Stock Chart ImmunityBio Stock Chart Mirum Pharmaceuticals Stock Chart Xenon Pharmaceuticals Stock Chart AMNEAL PHARMACEUTICALS Stock Chart Bausch Health Cos Stock Chart Gemini Therapeutics Stock Chart Apellis Pharmaceuticals Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
